LCRF applauds the commitment of the White House to making cancer a livable condition rather than a death sentence; reducing cancer death by 50% in the next 25 years, as President Biden announced yesterday with the reintroduction of the Cancer Moonshot.

“At LCRF, we’re committed to funding the research that will make this possible for the approximately 500,000 people living with lung cancer in the United States today,” said Dennis Chillemi, LCRF Executive Director. “It has been our mission since our inception and remains our true north to this day.”

Funding for research that leads to treatment breakthroughs is crucial to reaching the goal set by this initiative. Combined with improved detection, better access to affordable care, and community supports, we are encouraged by this renewed commitment to cancer patients, their caregivers, and the community that surrounds them.

Read more about Cancer Moonshot here.